Scientists test how body handles new cholesterol drug
NCT ID NCT06858865
Summary
This study aimed to understand how the body processes a new, single-pill cholesterol drug (AD-228A) compared to taking two separate pills (AD-2281 and AD-2282). It involved 60 healthy adult volunteers to measure drug levels in the blood and check for safety. The goal was to gather basic information to help design future studies for people with high cholesterol.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRIMARY HYPERCHOLESTEROLAEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
H+ Yangji Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.